CPDR Patient Education Program
Agent Orange and Prostate Cancer
Veterans diagnosed with prostate cancer may qualify for service-connected disability compensation.
Special Clinic at WRNMMC for Men with Prostate Cancer
The Center for Prostate Disease Research (CPDR) at Walter Reed National Military Medical Center (WRNMMC) has a special clinic for men diagnosed with prostate cancer called the "Multi-Disciplinary Prostate Cancer Clinic".
Patient Education Links
American Cancer Society
National Cancer Institute
National Comprehensive Cancer Network
Us TOO International Prostate Cancer Education and Support Network
American Urological Association
Prostate Cancer Research Institute
The John Hopkins Prostate Bulletin
Us TOO Hotsheets
WRNMMC Us TOO Newsletter
September 29, 2014
Genomic Health Announces Positive Results from Latest Clinical Validation Study of Oncotype DX® as Predictor of Near- and Long-term Outcomes in Racially Diverse Group of Prostate Cancer Patients
REDWOOD CITY, CA – Genomic Health, Inc. (Nasdaq: GHDX) today announced strongly positive results from an additional independent clinical validation study of the Oncotype DX® prostate cancer test, conducted in collaboration with the Uniformed Services University of the Health Sciences' (USU) Center for Prostate Disease Research (CPDR) supported by a multi-disciplinary team of investigators under a cooperative research and development agreement with USU. This new large study reconfirmed the biopsy-based test's Genomic Prostate Score (GPS) as a predictor of adverse pathology at surgery and, for the first time, validated GPS as a strong independent predictor of a rise in prostate-specific antigen (PSA) following surgery (biochemical recurrence).
Read Full Article.
Read Publication - European Urology
Read the NOVEMEBR 2014 Newsletter